Close

Analyst Ratings for Par Pharmaceutical (PRX)

PRX Rating Summary

  |   Expand Research on PRX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 1.1 / 10   Percentile Rank: 15%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/8/2012 UBS N/A Downgrade Neutral
(Buy)
N/A
(N/A)
50.02
(49.98)
-0.08% Details
7/20/2012 ThinkEquity N/A Downgrade Hold
(Buy)
50.00
(N/A)
50.05
(49.98)
-0.14% Details